報價延遲最少15分鐘:2025/07/03 06:20 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
100.9 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
2.34/5.82
|
|
企業價值
14.97B
|
| 資產負債 |
|
每股賬面淨值
64.79
|
| 現金流量 |
|
現金流量率
0.05
|
| 損益表 |
|
收益
2.76B
|
|
每股收益
23.72
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/03 06:20 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includesimmunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software. |